Covered recipient · General Payments record
BRIELLE BYRD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$405.64
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $345.46 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $72.46 | 4 |
| PFIZER INC. | $72.44 | 3 |
| Corium, Inc. | $42.85 | 2 |
| TOLMAR, INC. | $36.92 | 2 |
| Acella Pharmaceuticals, LLC | $25.83 | 1 |
| Tris Pharma Inc | $22.75 | 1 |
| Lilly USA, LLC | $19.58 | 1 |
| Neos Therapeutics, LP | $18.36 | 1 |
| Exact Sciences Corporation | $17.97 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.72 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106859381 | CMS |
| ABBVIE INC. | $22.37 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106859383 | CMS |
| ABBVIE INC. | $18.43 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106859385 | CMS |
| ABBVIE INC. | $17.94 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106859387 | CMS |
| Acella Pharmaceuticals, LLC | $25.83 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126637288 | CMS |
| Corium, LLC | $3.55 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100134604 | CMS |
| Corium, LLC | $39.30 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100206038 | CMS |
| Exact Sciences Corporation | $17.97 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114604281 | CMS |
| Lilly USA, LLC | $19.58 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135607455 | CMS |
| Neos Therapeutics, LP | $18.36 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082664111 | CMS |
| PFIZER INC. | $27.86 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132045520 | CMS |
| PFIZER INC. | $17.83 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132047560 | CMS |
| PFIZER INC. | $26.75 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132119520 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.30 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137720834 | CMS |
| Tolmar, Inc. | $18.60 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138710724 | CMS |
| Tolmar, Inc. | $18.32 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138718310 | CMS |
| Tris Pharma Inc | $22.75 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147225781 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.